ENTITY

Reviva Pharmaceuticals Holdi (RVPH US)

Analysis

Health Care • United States

Reviva Pharmaceuticals Holdings, Inc. operates as a clinical development pharmaceutical company. The Company focuses on developing a portfolio of internally discovered therapies that address unmet medical needs in the areas of central nervous system (CNS), cardiovascular, metabolic, and inflammatory diseases. Reviva Pharmaceuticals Holdings serves customers worldwide.

Refresh

No presentations found

We’ll display presentations we find for Reviva Pharmaceuticals Holdi here

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00